Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare
- PMID: 26700439
- PMCID: PMC4702227
- DOI: 10.2215/CJN.03990415
Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare
Abstract
Background and objectives: Autoantibodies to complement C1q (anti-C1q) are associated with the diagnosis of lupus nephritis. In this study, we compare anti-C1q IgG with another complement autoantibody, anti-C3b IgG, as a biomarker of lupus nephritis and lupus nephritis flare.
Design, setting, participants, & measurements: Our investigation involved the Ohio SLE Study, a prospective observational cohort of patients with recurrently active lupus who were followed bimonthly. Serum anti-C1q and anti-C3b IgG levels were assessed cross-sectionally by ELISA in 40 normal controls and 114 patients in the Ohio SLE Study (41 nonrenal and 73 lupus nephritis) at study entry, and longitudinally in a subset of patients in the Ohio SLE Study with anti-C1q-positive lupus nephritis in samples collected every 2 months for 8 months leading up to lupus nephritis flare (n=16 patients).
Results: In the cross-sectional analysis, compared with anti-C1q IgG, anti-C3b IgG was less sensitive (36% versus 63%) but more specific (98% versus 71%) for lupus nephritis. Only anti-C3b IgG was associated with patients with lupus nephritis who experienced at least one lupus nephritis flare during the Ohio SLE Study period (P<0.01). In the longitudinal analysis, circulating levels of anti-C1q IgG increased at the time of lupus nephritis flare only in patients who were anti-C3b positive (P=0.02), with significant increases occurring from 6 (38% increase) and 4 months (41% increase) before flare. Anti-C3b IgG levels also trended up at lupus nephritis flare, although the change did not reach statistical significance (P=0.07). Neither autoantibody increased 2 months before flare.
Conclusions: Although not as prevalent as anti-C1q IgG, anti-C3b IgG showed nearly complete specificity for lupus nephritis. The presence of anti-C3b IgG identified patients with lupus nephritis who were prone to flare and in whom serial measurements of markers associated with complement, such as anti-C1q IgG, may be useful to monitor lupus nephritis activity.
Keywords: anti-C1q; anti-C3b; autoantibodies; complement C1q; cross-sectional studies; flare; humans; immunoglobulin G; lupus nephritis; prospective studies.
Copyright © 2016 by the American Society of Nephrology.
Figures
Comment in
-
Lupus Nephritis in the Era of Biomarkers.Clin J Am Soc Nephrol. 2016 Jan 7;11(1):4-5. doi: 10.2215/CJN.12371115. Epub 2015 Dec 23. Clin J Am Soc Nephrol. 2016. PMID: 26700438 Free PMC article. No abstract available.
References
-
- Siegert C, Daha M, Westedt ML, van der Voort E, Breedveld F: IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 18: 230–234, 1991 - PubMed
-
- Yin Y, Wu X, Shan G, Zhang X: Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: A meta-analysis. Lupus 21: 1088–1097, 2012 - PubMed
-
- Rovin BH, Tang Y, Sun J, Nagaraja HN, Hackshaw KV, Gray L, Rice R, Birmingham DJ, Yu CY, Spetie DN, Aziz A, Hebert LA: Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy. Kidney Int 68: 747–759, 2005 - PubMed
-
- Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN: Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol 16: 467–473, 2005 - PubMed
-
- Birmingham DJ, Nagaraja HN, Rovin BH, Spetie L, Zhao Y, Li X, Hackshaw KV, Yu CY, Malarkey WB, Hebert LA: Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele. Arthritis Rheum 54: 3291–3299, 2006 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
